Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A multi-disciplinary team of researchers in Oxford and Newcastle, led by Professor Rutger Ploeg from the Nuffield Department of Surgical Sciences, has been awarded a grant of £1.7 million from the Medical Research Council. The four-year grant will enable the expansion of the successful Quality in Organ Donation (QUOD) initiative, currently funded and supported by NHS Blood and Transplant.

QUOD concerns a national consortium, rolled out in 2014, to facilitate research on donor organ quality and how organs can be better utilized to increase the number of transplants in the United Kingdom. This unique national resource combines detailed clinical information from virtually all organ donors in the UK with a biobank of blood, urine, and tissue samples taken around the time of donation. Such a combination of data and samples has enabled research on the mechanisms of organ damage and repair, leading to better selection and optimisation of organs for successful transplantation.

Until now, QUOD has focused on kidney and liver donors, but the MRC grant will allow the QUOD biobank to collect samples for research from heart, lung, and pancreatic donors. Furthermore, the grant will allow QUOD to create scientific platforms including state-of-the-art pathology, genomics, proteomics, and imaging techniques to develop online searchable atlases, representing a spectrum of normal, stressed, and chronically diseased organs.

The science and technology platforms involve multidisciplinary teams of scientists, clinicians, and other health care professionals, including Professors James Shaw, John Dark, and Dina Tiniakos in Newcastle, and Professors Benedikt Kessler, Anna Gloyn, and Paul Johnson in Oxford.

This connection of high-quality clinical information, easily monitored samples, and newly identified biomarkers does not currently exist. The QUOD expansion will thus create invaluable tools for the scientific and clinical community. It will facilitate new understanding of the causes of organ stress, leading to new treatments to maximise transplant success but may also help to prevent or even reverse chronic diseases without the need for transplantation.

Ultimately, the QUOD expansion aims to further the overall QUOD mission: saving lives and cutting health care costs by increasing the pool of transplantable organs, thereby addressing the growing gap between supply and demand in organ transplantation.

Present and future QUOD resources benefit researchers in academia and industry across the country. For more information on QUOD, including how to access samples for research, please visit the QUOD website.

 

Logos

Similar stories

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

NDS SITU host first ever Surgical Trials Showcase

The first ever showcase of the Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences (NDS SITU) was hosted on Monday 23 January 2023 at the Richard Doll Building on Old Road Campus, Oxford, and also online.

Mr Gurdeep S. Mannu awarded Cancer Research UK Clinician Scientist Fellowship

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

Blog posts

Marathon challenge for Prostate Cancer UK

Runners of all abilities started 2023 by challenging themselves to run 26.2 miles across January to fundraise for Prostate Cancer UK as part of the charity’s Run the Month: Marathon Edition.

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.